NYSE$WELL
Welltower Inc · Q4 2022 earnings
Q4 2022 earnings · · Investor relations
Briefing
Announced Q4 2022 results, highlighted by significant SSNOI growth and strategic portfolio transitions.
Welltower reported a net loss of $0.01 per diluted share and normalized FFO of $0.83 per diluted share for Q4 2022. The company experienced strong same-store NOI growth, particularly in its Seniors Housing Operating portfolio, and made strategic moves to optimize its portfolio, including forming a joint venture with Integra Healthcare Properties.
- Net loss attributable to common stockholders was $0.01 per diluted share.
- Normalized FFO attributable to common stockholders was $0.83 per diluted share.
- Total portfolio year-over-year same-store NOI grew by 12.9%, driven by a 28.1% increase in the Seniors Housing Operating portfolio.
- Formed a joint venture with Integra Healthcare Properties and transitioned operations for skilled nursing assets previously managed by ProMedica.
Headline financials
Revenue & EPS history
Welltower · Revenue · Quarterly
$1.52B
Revenue by segment
Welltower · $1.2B total across 1 segment · Q3 2023
- Resident fees and services$1.2B+12.7%100.0%
Forward guidance
Welltower introduced its 2023 earnings guidance, projecting net income per share between $0.57 and $0.75 and normalized FFO per share between $3.35 and $3.53. The guidance assumes blended SSNOI growth of 8% to 13%.
Tailwinds
- Expect average blended SSNOI growth of 8% to 13%.
- Seniors Housing Operating SSNOI growth approximately 15% to 24%.
- Seniors Housing Triple-net SSNOI growth approximately 1% to 3%.
- Outpatient Medical SSNOI growth approximately 2% to 3%.
- Long-Term/Post-Acute Care SSNOI growth approximately 2% to 3%.
Headwinds
- Increased interest rates on floating rate debt.
- Strengthening U.S. Dollar relative to the British Pound and Canadian Dollar are expected to reduce 2023 normalized FFO attributable to common stockholders by approximately $0.19 per diluted share versus 2022.
- Earnings guidance includes only those acquisitions closed or announced to date.
- No transitions or restructures beyond those announced to date are included.
- Guidance does not include the recognition of any Provider Relief Funds or other government grants which may be received during the year.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2022
+0.7%
Avg return
Earnings day
+2.2%
Avg return
5 days after
+3.0%
Avg return
30 days after
61%
43 / 70 earnings
Positive
+9.1%
Q3 2022
Best reaction
-12.9%
Q1 2020
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -1.0% | +1.4% | -3.9% | |
| Q4 2025 | +3.5% | +4.9% | +3.5% | |
| Q3 2025 | -1.6% | -0.9% | +12.9% | |
| Q2 2025 | +0.6% | +2.5% | +4.5% | |
| Q1 2025 | +1.6% | +1.1% | +2.7% | |
| Q4 2024 | +2.2% | +4.6% | +3.1% | |
| Q3 2024 | +5.5% | +2.4% | +7.0% | |
| Q2 2024 | +2.2% | +2.7% | +10.3% | |
| Q1 2024 | +1.0% | +1.6% | +6.7% | |
| Q4 2023 | +6.6% | +6.4% | +4.7% | |
| Q3 2023 | +2.8% | +8.7% | +8.4% | |
| Q2 2023 | +4.4% | +1.7% | +2.3% | |
| Q1 2023 | -0.9% | +0.6% | -4.7% | |
| Q4 2022 | +3.0% | +2.2% | -9.2% | |
| Q3 2022 | +9.1% | +17.4% | +6.6% | |
| Q2 2022 | +2.1% | +1.3% | -6.4% | |
| Q1 2022 | -0.1% | +1.5% | -4.4% | |
| Q4 2021 | +5.3% | +4.0% | +15.5% | |
| Q3 2021 | +2.1% | +3.1% | -2.9% | |
| Q2 2021 | -0.6% | -0.3% | -2.0% | |
| Q1 2021 | -0.5% | +0.0% | -2.2% | |
| Q4 2020 | +2.7% | +6.8% | +16.1% | |
| Q3 2020 | +1.1% | +5.0% | +19.5% | |
| Q2 2020 | +5.9% | +7.8% | +14.7% | |
| Q1 2020 | -12.9% | -12.7% | +27.8% | |
| Q4 2019 | +3.3% | +5.2% | -39.6% | |
| Q3 2019 | +1.7% | +2.4% | -2.4% | |
| Q2 2019 | -0.3% | +1.1% | +6.7% | |
| Q1 2019 | +2.6% | +4.7% | +10.6% | |
| Q4 2018 | +0.2% | +0.2% | +0.6% | |
| Q3 2018 | +0.1% | -0.2% | +8.3% | |
| Q2 2018 | -4.1% | -2.1% | +2.5% | |
| Q1 2018 | +4.7% | +8.6% | +12.6% | |
| Q4 2017 | +0.8% | -3.3% | -3.6% | |
| Q3 2017 | +1.1% | +0.2% | -2.7% | |
| Q2 2017 | +0.8% | -0.5% | -1.2% | |
| Q1 2017 | -0.2% | +0.2% | +5.6% | |
| Q4 2016 | +2.9% | +4.6% | +4.1% | |
| Q3 2016 | -2.1% | -1.7% | -6.9% | |
| Q2 2016 | -2.7% | -4.1% | -4.0% | |
| Q1 2016 | +5.8% | — | — | |
| Q4 2015 | +4.7% | — | — | |
| Q3 2015 | -1.6% | — | — | |
| Q2 2015 | -1.8% | — | — | |
| Q1 2015 | -1.0% | — | — | |
| Q4 2014 | +3.2% | — | — | |
| Q3 2014 | +0.4% | — | — | |
| Q2 2014 | +1.7% | — | — | |
| Q1 2014 | +1.2% | — | — | |
| Q4 2013 | -0.7% | — | — | |
| Q3 2013 | -2.8% | — | — | |
| Q2 2013 | -0.9% | — | — | |
| Q1 2013 | -1.3% | — | — | |
| Q4 2012 | -2.0% | — | — | |
| Q3 2012 | +1.5% | — | — | |
| Q2 2012 | -3.3% | — | — | |
| Q1 2012 | -1.2% | — | — | |
| Q4 2011 | -2.6% | — | — | |
| Q3 2011 | -4.3% | — | — | |
| Q2 2011 | +5.6% | — | — | |
| Q1 2010 | +0.2% | — | — | |
| Q1 2011 | -0.2% | — | — | |
| Q4 2009 | +1.7% | — | — | |
| Q4 2010 | +1.7% | — | — | |
| Q1 2009 | +1.7% | — | — | |
| Q4 2008 | +1.7% | — | — | |
| Q3 2009 | -4.4% | — | — | |
| Q3 2010 | -4.4% | — | — | |
| Q2 2010 | +0.2% | — | — | |
| Q2 2009 | +0.2% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro